Drug Delivery Business

minimed

Medtronic wins FDA clearance for MiniMed Go app for InPen smart insulin pen

By

Medtronic (NYSE:MDT) announced today that the FDA granted 510(k) clearance for its MiniMed Go app for multiple daily injections (MDI). MiniMed Go, a smart MDI system, integrates the InPen smart insulin pen with the Instinct sensor made by Abbott. It all integrates within the app to deliver real-time, personalized insights and actionable guidance. Medtronic and […]

Medtronic expands US pharmacy formulary access for MiniMed 780G

By

Medtronic (NYSE:MDT) announced today that it expanded U.S. pharmacy formulary access for its MiniMed 780G insulin pump. The medtech giant’s Diabetes business unit — set to become a standalone public company called MiniMed through an IPO — said it struck agreements with major pharmacy benefit managers (PBMs) and PBM group purchasing organizations (GPOs), including Ascent and […]

Medtronic touts time in range outcomes with MiniMed 780G

By

Medtronic (NYSE:MDT) today announced a new real-world retrospective analysis highlighting positive outcomes with its MiniMed 780G. The medtech giant’s Diabetes business, which recently took the next step toward becoming a standalone public company called MiniMed through an IPO, said MiniMed 780G achieved American Diabetes Association (ADA)-recommended goals for time-in-range (TIR), even on days when mealtime […]

Medtronic Diabetes unit MiniMed files for IPO

By

Medtronic (NYSE:MDT) announced today that its MiniMed Diabetes business filed with the SEC for a proposed initial public offering (IPO). The medtech giant said MiniMed filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC). It expects to complete the separation from Medtronic through a series of capital markets transactions. […]

Medtronic rolls out MiniMed campaign for launch with Instinct sensor made by Abbott

By

Medtronic (NYSE:MDT) announced the launch of its “Own It” campaign for the rollout of its MiniMed 780G system and Instinct sensor made by Abbott. The campaign aims to bring awareness to the now available system that “works quietly in the background” while people with type 1 diabetes can go about their daily lives. Medtronic (soon […]

Medtronic studies highlight MiniMed 780G’s cost-effectiveness

By

Medtronic (NYSE: MDT) today announced new data demonstrating the health economic benefits of its MiniMed 780G system. Findings highlighted the advanced hybrid closed-loop automated insulin delivery system’s benefits compared to the standard of care using multiple daily injections (MDI) with intermittently scanned continuous glucose monitoring (isCGM). MiniMed 780G, Medtronic’s latest-generation automated insulin delivery system, provides real-time […]

Medtronic has a new head of investor relations, former head to join Diabetes spin-off MiniMed

By

Medtronic (NYSE: MDT) announced today that it named Ingrid Goldberg as its new VP and head of investor relations (IR). Goldberg’s appointment comes as Ryan Weispfenning, who previously held that role, elected to join the company’s Diabetes business and lead the IR function for the unit as it continues to work toward a separation from […]

Medtronic begins full commercial rollout of MiniMed 780G with Instinct sensor made by Abbott

By

Medtronic (NYSE:MDT) today announced the full U.S. launch for its Instinct sensor, made by Abbott, paired with the MiniMed 780G pump. The medtech giant’s diabetes unit — one of the largest diabetes tech businesses in the world — won FDA clearance for its SmartGuard algorithm as an interoperable automated glycemic controller (iAGC) earlier this year, enabling […]

Medtronic Diabetes to submit patch pump to FDA by fall 2026, separation remains on track

By

Medtronic officials today said the planned separation of its Diabetes business (MiniMed) remains on track, with future offerings also on the horizon. On the company’s second-quarter earnings call, CFO Thierry Piéton outlined the expected timelines for the Diabetes business, following another quarter of significant growth. Global Diabetes revenues grew 10.3% year over year, despite a […]

12 things you need to know about the CGM market

By

The CGM market is an exciting, fast-growing, multibillion-dollar sector for the medical device industry, according to our latest Medtech Market Intelligence Report for MassDevice. The report on the CGM market — available for purchase on MassDevice — draws on numerous sources, including but not limited to: medical associations, government data, medical journals, leading medtech publications, clinical […]